Healthcare Value Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Healthcare Value Capital’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-952	Closed	-$343K	–	34
2015 Q2	$602K	Hold	952	–	–	0.63%	26
2015 Q1	$490K	Hold	952	–	–	0.53%	31
2014 Q4	$510K	Buy	952 +833	+700%	+$375K	0.93%	19
2014 Q3	$179K	Buy	+119	New	+$172K	0.17%	31
2014 Q2	–	Sell	-491	Closed	-$570K	–	40
2014 Q1	$682K	Buy	491 +95	+24%	+$110K	0.45%	33
2013 Q4	$394K	Hold	396	–	–	0.29%	34
2013 Q3	$413K	Hold	396	–	–	0.36%	43
2013 Q2	$432K	Buy	+396	New	+$441K	0.31%	52

Other funds holding VIRX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Healthcare Value Capital's VIRX Position: Q3 2015 in Review

Healthcare Value Capital sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2015, closing a stake of 952 shares — an estimated $343K sold.

Healthcare Value Capital first reported a position in VIRX in Q2 2013 and held it in 8 quarters. The position peaked at $682K in Q1 2014. 59 funds tracked by Wall St. Rank hold VIRX as of Q3 2015.

Healthcare Value Capital reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Healthcare Value Capital sold 952 Viracta Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $343K.
Healthcare Value Capital first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Healthcare Value Capital's Viracta Therapeutics, Inc. Common Stock position peaked at $682K in Q1 2014.
59 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Healthcare Value Capital's 13F filing for Q3 2015, filed 16 Nov 2015.